The Cancer Research Institutions Matching Fund established in KRS 164.043 is administered by the Council on Postsecondary Education to support cancer-related research that will ultimately reduce the morbidity and mortality from these diseases. The program is funded by a one cent per pack cigarette surtax, and the two research institutions – UK and U of L-provide a dollar for dollar match from external sources.
I he Southern Regional Education Board (SREB) Doctoral Scholars Program supports and encourages students to pursue doctoral degrees. The goal of the program is to increase the number of students who earn doctorates and choose to become faculty at colleges and universities. Students are provided scholarships and other support to attend institutions throughout the southern region and in some Midwest states.
The Ovarian Cancer Screening Program supports early cancer screening at the University of Kentucky. The program is an ongoing, 38-year research study showing that annual screening continues to detect ovarian cancer at an earlier stage than is possible with a clinical examination.
The Cancer Research and Screening Programs at the University of Kentucky and the University of Louisville support research and clinical trials to benefit the citizens of Kentucky.
The Spinal Cord and Head Injury Research Program, codified in KRS 211.500 through 211.504, funds spinal cord and head injury research undertaken at the University of Kentucky and the University of Louisville. The funding is administered by the Kentucky Spinal Cord and Head Injury Research Board.
The Kentucky State University Fiscal Stabilization Program was established as a result of House Bill 250 enacted by the 2022 General Assembly. In that act, the General Assembly appropriated funding to Kentucky State University (KSU) to avert a fiscal crisis and provided strategic operating funds to KSU to be distributed by CPE. The act also required CPE to provide ongoing oversight of KSU's progress toward the goals outlined in its management improvement plan.
Tobacco Settlement Funds in the amount of $6,250,000 in fiscal year 2027 and $5,480,300 in fiscal year 2028 and Restricted Funds from interest earnings from the Healthcare Improvement Fund in the amount of $769,700 in fiscal year 2028 are included for Cancer Research and Screening, which is shared equally between the University of Kentucky's Markey Cancer Center and the University of Louisville's Brown Cancer Center.